AbtBioConsult ApS: Financial statements 2024
CVR: 42368660
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
AbtBioConsult ApS (CVR 42368660) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,641,200 and a net result of DKK 485,221 compared with DKK -626,623 the year before. That is an increase of 14.8% compared with the year before. Equity in the 2024 report amounted to DKK 4,330,360. The solvency ratio was 93.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,641,200
- Profit/Loss
- DKK 485,221
- Equity
- DKK 4,330,360
- Total Assets
- DKK 4,622,840
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.6 mio. | 485 t. | 4.3 mio. | 1 |
| 2023 | - | 1.4 mio. | -627 t. | 3.8 mio. | 1 |
| 2022 | - | 1.9 mio. | -434 t. | 4.9 mio. | 1 |
| 2021 | - | 2.5 mio. | -575 t. | 5.3 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
AbtBioConsult ApS has published its annual report for 2023. Gross profit came to DKK 1,429,097, and the net result was DKK -626,623.
About AbtBioConsult ApS
AbtBioConsult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anne Bondgaard Tolstrup. The company is owned by Anne Bondgaard Tolstrup. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,937,411 and a net result of DKK 692,691 compared with DKK 485,221 the year before. Equity in the 2025 report amounted to DKK 4,523,051.